1887

Abstract

SUMMARY

A new inactivation process for foot-and-mouth disease virus (FMDV) has been developed. This process is based on the activation of the FMDV endonuclease by incubation of unfractionated viral suspension or purified virions at 37 °C in the presence of high concentrations of monovalent cations such as K, Cs or NH at pH 8.5. This procedure completely inactivated several FMDV vaccine strains yielding preparations having similar amounts of 140S particles to untreated controls. The inactivation followed first-order kinetics and the rate of inactivation was faster than that achieved with other agents, e.g. binary ethyleneimine. Testing in suckling mice or tissue culture revealed no residual infectivity after inactivation. Virus particles purified from inactivated preparations showed (i) the same sedimentation coefficient as non-inactivated preparations, (ii) electrophoretic patterns of their viral capsid proteins identical to those derived from non-inactivated preparations, and (iii) extensive degradation of the 35S viral RNA. This method is safer than inactivation with aziridines because only innocuous chemicals are used in the process.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-65-9-1567
1984-09-01
2021-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/65/9/JV0650091567.html?itemId=/content/journal/jgv/10.1099/0022-1317-65-9-1567&mimeType=html&fmt=ahah

References

  1. Anderson E. C., Capstick P. B., Mowat G. N., Leech F. B. 1970; In vitro method for safety testing of foot and mouth disease vaccines. Journal of Hygiene 68:159–172
    [Google Scholar]
  2. Bachrach H. L., Vande Woude G. F. 1968; Amino acid composition and C-terminal sequence of foot and mouth disease virus protein. Virology 34:282–289
    [Google Scholar]
  3. Bachrach H. L., Moore D. M., McKercher P. D., Polatnick J. 1975; Immune and antibody responses to an isolated capsid protein of FMDV. Journal of Immunology 115:1636–1641
    [Google Scholar]
  4. Bittle J. L., Houghten R. A., Alexander H., Shinnik T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. 1982; Protection against foot-and-mouth disease by immunisation with a chemically synthesised peptide predicted from the viral nucleotide sequence. Nature, London 298:30–33
    [Google Scholar]
  5. Boothroyd J. C., Highfield P. E., Cross G. A. M., Rowlands D. J., Lowe P. A., Brown F., Harris T. J. R. 1981; Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes. Nature, London 290:800–802
    [Google Scholar]
  6. Brown F., Wild T. F. 1966; The effect of heat on the structure of foot-and-mouth disease virus and the viral ribonucleic acid. Biochimica et biophysica acta 119:301–308
    [Google Scholar]
  7. Denoya C. D., Scodeller E. A., Vasquez C., La Torre J. L. 1978a; Ribonuclease activities associated with purified foot-and-mouth disease virus. Archives of Virology 57:153–159
    [Google Scholar]
  8. Denoya C. D., Scodeller E. A., Vasquez C., La Torre J. L. 1978b; Foot-and-mouth disease virus. II Endoribonuclease activity within purified virions. Virology 89:67–74
    [Google Scholar]
  9. Doel T. R., Baccarini P. J. 1981; Thermal stability of foot-and-mouth disease virus. Archives of Virology 70:21–32
    [Google Scholar]
  10. Esionov A. V., Nikitin E. E. 1967; A comparative study of the immunogenic properties of ‘alkaline’ thermovaccine against the A variant of FMD. Aktualinye voprosy195–196
    [Google Scholar]
  11. Graves J. H., Arlinghaus R. B. 1968; Acetylethyleneimine in the preparation of inactivated foot-and-mouth disease vaccine. Proceedings of the Meeting of the V.S. Livestock Sanitary Association 71:396–403
    [Google Scholar]
  12. King A. M. Q., Underwood B. O., McCahon D., Newman J. W. L., Brown F. 1981; Biochemical identification of the virus causing the 1981 outbreak of foot-and-mouth disease virus in Britain. Nature, London 293:479–480
    [Google Scholar]
  13. Kleid D. G., Yansura D., Small B., Dowbenko D., Moore D. M., Grubman M. V., McKercher P. D., Morgan D. O., Robertson B. H., Bachrach H. L. 1981; Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214:1125–1129
    [Google Scholar]
  14. Kupper H., Keller W., Kurz C., Porss S., Schaller H., Franze R., Strohmaier K., Marquardt O., Zaslavsky V. G., Hofschneider P. H. 1981; Cloning of CDNA of major antigen of foot-and-mouth disease virus and expression in E. coli. Nature, London 289:555–559
    [Google Scholar]
  15. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 211:680–685
    [Google Scholar]
  16. Moosbrugger G. A. 1948; Recherches experimentales sur la Fievre Aphteuse. Schweizer Archivfür Tierheilkunde 90:176–178
    [Google Scholar]
  17. Perry R. P., La Torre J. L., Kelley D. E., Greenberg J. R. 1972; On the lability of poly(A) sequences during extraction of messenger RNA from polyribosomes. Biochimica et biophysica acta 262:220–226
    [Google Scholar]
  18. Schneider B. 1955; Pathogenicity of adsorbed vaccines against foot-and-mouth disease. Monatshefte für Tierheilkunde 7:81–87
    [Google Scholar]
  19. Ward R. L. 1978; Mechanism of poliovirus inactivation by ammonia. Journal of Virology 26:299–305
    [Google Scholar]
  20. Wild T. F., Brown F. 1968; A study of the physical properties of the immunising antigen of FMD virus and the effect of various inactivating agents on its structure. Archiv für die gesamte Virusforschung 24:86–103
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-65-9-1567
Loading
/content/journal/jgv/10.1099/0022-1317-65-9-1567
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error